BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biotech

Kyowa Kirin Taps Cognizant and Benchling to Build AI-Powered Drug Discovery Foundation in Japan

Cognizant announced that it will support the introduction and implementation of Benchling, the AI platform for R&D at Tokyo Research Park and Fuji Rese...

August 17, 2026 | News

6 Radiopharmaceutical Programmes and Sites to Watch in APAC

Radioligand therapy is the one modality a region cannot buy its way into late. A vial of lutetium-177 loses half its therapeutic activity in roughly six an...

August 17, 2026 | Analysis

Thermo Fisher Scientific and KYAN Technologies Sign MoU to Advance Functional Precision Oncology for Solid Tumours

Thermo Fisher Scientific and KYAN Technologies have signed a Memorandum of Understanding (MoU) to collaborate on advancing functional precision oncology ap...

August 14, 2026 | News

From Market Access to Long-Term Growth: Rethinking Biopharma Expansion in APAC

BioPharma APAC speaks with Girisan Kariangal, Regional Vice President – Business Development & Alliance Management, Menarini Asia-Pacific, on the...

August 04, 2026 | Interaction

Eppendorf to Invest EUR 40 Million in New Penang Manufacturing Facility

Eppendorf has signed an agreement for a new production site in Penang, Malaysia, marking the start of its planned greenfield manufacturing facility in Band...

July 30, 2026 | News

Waters Launches Next-Generation IVD Mass Spectrometer for High-Sensitivity Clinical Diagnostics

Brings Xevo™ TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, c...

July 29, 2026 | News

Jyong Biotech Expands Global Licensing Push for Botanical Therapy Targeting Enlarging BPH Market

Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercializa...

July 29, 2026 | News

The Bioreactors Are Ours. The Consumables Are Not.

A new biologics plant is one of the easier things in medicine to photograph. The bioreactors are large and gleaming, the capacity figures are big and round...

July 22, 2026 | Analysis

Akeso Doses First Patient in Phase II Trial of AK146D1–Ivonescimab Combination for Advanced NSCLC

Akeso, Inc. (9926.HK) (announced that the first patient has been dosed in a Phase II clinical study (AK146D1-201) evaluating its internally developed TROP2...

July 21, 2026 | News

After the Rush: APAC's mRNA and Vaccine Capacity Hangover

In June 2022, South Korea had something it had wanted for two years: a COVID-19 vaccine of its own. SKYCovione, developed by SK bioscience with the U...

July 08, 2026 | Analysis

Can APAC Build Radioligand Therapy Before the Atoms Decay?

Every dose of radioligand therapy is a countdown. The moment a batch of lutetium-177 leaves the reactor, it begins to fade — roughly half its therape...

July 02, 2026 | Analysis

Merck Expands Life Science Leadership with Planned $11.3 Billion Bio-Techne Acquisition

Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion) Proposed acquisition expected to be immedi...

June 26, 2026 | News

ChemT Biotechnology Raises US$5 Million to Advance AI-Powered Biomanufacturing Platform

The total funding comprises US$1 million in angel investment and a US$4 million seed round. The seed financing round was led by Wavem...

June 23, 2026 | News

Billions on Bioconjugation: Is APAC Building the Right ADC Capacity — or Too Much?

In Songdo, on the reclaimed waterfront west of Seoul, a 202,000-square-metre construction site is becoming the most expensive single statement Kore...

June 19, 2026 | Analysis

Stay Connected